BioPharmSignal logoBioPharmSignal

Biotech News

Molina Healthcare Reports Fourth Quarter and Year-End 2025 Financial Results

Molina Healthcare (MOH)Molina Healthcare2026-02-05 21:15 ESTEarnings

Introduces Full Year 2026 Revenue and Earnings Guidance LONG BEACH, Calif. --(BUSINESS WIRE)--Feb. 5, 2026-- Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported fourth quarter 2025 GAAP loss per diluted share of $3.15 and adjusted loss per diluted share of $2.75.

Open original release

Related news

MOHMolina Healthcare2026-07-22 20:15 EST

Molina Healthcare Reports Second Quarter 2026 Financial Results

MOHMolina Healthcare2026-06-10 20:15 EST

Molina Healthcare Wins Illinois Medicaid Contract

MOHMolina Healthcare2026-06-02 13:00 EST

Molina Healthcare Announces Second Quarter 2026 Earnings Release and Conference Call Dates

MOHMolina Healthcare2026-04-22 20:15 EST

Molina Healthcare Reports First Quarter 2026 Financial Results

MOHMolina Healthcare2026-02-26 21:15 EST

Molina Healthcare Announces First Quarter 2026 Earnings Release and Conferences Call Dates and Investor Day Meeting

MOHMolina Healthcare2025-12-30 21:15 EST

Molina Healthcare Announces Fourth Quarter and Year-End 2025 Earnings Release and Conference Call Dates

MOHMolina Healthcare2025-11-20 21:15 EST

Molina Healthcare Announces Closing of Offering of $850 Million of 6.500% Senior Notes Due 2031

MOHMolina Healthcare2025-11-17 23:10 EST

Molina Healthcare Announces Pricing of $850 Million of 6.500% Senior Notes Due 2031

MOHMolina Healthcare2025-11-17 13:20 EST

Molina Healthcare Announces Proposed Offering of $750 Million of Senior Notes Due 2031

MOHMolina Healthcare2025-11-14 14:00 EST

Molina Healthcare Awarded New Florida Medicaid Contract

View all latest news

Molina Healthcare

Molina Healthcare is a managed-care company focused on government-sponsored healthcare programs. Its story is driven by membership, medical-cost trends, and execution in Medicaid, Medicare, and marketplace businesses.

Recent company news

MOHBruker2026-07-24 20:01 EST

Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast

MOHQuest Diagnostics2026-07-23 10:45 EST

Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

MOHMolina Healthcare2026-07-22 20:15 EST

Molina Healthcare Reports Second Quarter 2026 Financial Results

MOHAxon Enterprise, Inc.2026-07-22 20:01 EST

Axon to Release Second Quarter 2026 Earnings on August 5, 2026

MOHGSK plc2026-07-22 11:21 EST

Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer

Stock data

Close
200.29 USD
Market cap
9.37B USD
Exchange
NYSE
Sector
Biopharma
Location
United States